MAP2K7 and cancer: These findings are consistent with other studies that showed that MEK inhibition increases cancer cell death induced by 5-ALA-PDT16 and that the activation of ERK, a downstream element of Ras/MEK, underlies cancer cell resistance to 5-ALA-PDT17.